World's Best Scientists 2026 revealed!
Endocrine, Metabolic and Immune Disorders - Drug Targets
H-index 16

Endocrine, Metabolic and Immune Disorders - Drug Targets

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Immunology 163 12 54 11
Medicine 2660 47 56 8

Additional Metrics

Number of Best Scientists*: 101
Documents by Best Scientists*: 150
Top 100 Ranked Scientists*: 3
SCIMAGO H-index: 66
SCIMAGO SJR: 0.535
Impact Factor: 2

Overview

Top Research Topics at Endocrine‚ Metabolic & Immune Disorders-Drug Targets?

The journal covers a variety of subjects, including Internal medicine, Endocrinology, Immunology, Immune system and Diabetes mellitus. Internal medicine and Gastroenterology are closely related fields of research discussed in it. The Endocrinology research presented places emphasis on topics like Hormone, Oxidative stress, Vitamin D and neurology and Thyroid.

It features Immunology research that overlaps with concepts in Disease. It focuses on Disease research which is adjacent to topics in Bioinformatics. It connects the study in Immune system with the closely related area of Antigen.

Endocrine‚ Metabolic & Immune Disorders-Drug Targets facilitated presentations on Diabetes mellitus research, particularly Type 2 diabetes, Streptozotocin and Type 2 Diabetes Mellitus. Many of the studies tackled connect Inflammation with a similar field of study like Pharmacology. The Obesity study featured in it draws connections with the study of Body mass index.

  • Internal medicine (35.54%)
  • Endocrinology (20.99%)
  • Immunology (16.99%)

What are the most cited papers published in the journal?

  • Traditional Chinese Medicine in Treatment of Metabolic Syndrome (278 citations)
  • Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect. (222 citations)
  • Epidemiology of severe sepsis around the world. (154 citations)

Research areas of the most cited articles at Endocrine‚ Metabolic & Immune Disorders-Drug Targets:

The journal articles are mainly concerned with subjects like Internal medicine, Immunology, Endocrinology, Immune system and Diabetes mellitus. The studies on Immunology discussed at the journal articles can also contribute to research in the domains of Receptor and NADPH oxidase. The published papers explore research in Endocrinology alongside concepts in Physiology and other areas of study in Hormone.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Gene
  • Cancer

The previous edition focused in particular on these issues:

The main points discussed in Endocrine‚ Metabolic & Immune Disorders-Drug Targets deals with Internal medicine, Diabetes mellitus, Endocrinology, Pharmacology and Disease. In addition to Internal medicine research, it aims to explore topics under Gastroenterology, Type 2 diabetes and Oncology. The study of Diabetes mellitus encompasses disciplines such as Antioxidant, as well as fields such as Traditional medicine, all of which overlap with one another.

Research on Endocrinology presented in it focuses, in particular, on Nitric oxide and Oxidative stress. Pharmacology study tackled is connected to the field of Inflammation. In particular, the Disease works presented emphasize discussions on Coronavirus disease 2019 (COVID-19).

The most cited articles from the last journal are:

  • Rebalancing the Oral Microbiota as an Efficient Tool in Endocrine, Metabolic and Immune Disorders. (15 citations)
  • An Alternative "Trojan Horse" Hypothesis for COVID-19: Immune Deficiency of IL-10 and SARS-CoV-2 Biology. (8 citations)
  • Oxytocin as a Potential Adjuvant against COVID-19 Infection. (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Endocrine‚ Metabolic & Immune Disorders-Drug Targets (based on the number of publications) are:

  • Vincenzo Triggiani (62 papers) published 10 papers at the last edition, 2 more than at the previous edition,
  • Edoardo Guastamacchia (45 papers) published 8 papers at the last edition, 3 more than at the previous edition,
  • Thea Magrone (40 papers) published 5 papers at the last edition, 4 less than at the previous edition,
  • Vito Angelo Giagulli (37 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • Giovanni De Pergola (29 papers) published 6 papers at the last edition, 1 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Endocrine‚ Metabolic & Immune Disorders-Drug Targets (based on the number of publications) are:

  • University of Bari (149 papers) published 29 papers at the last edition the same number as at the previous edition,
  • Tehran University of Medical Sciences (42 papers) published 18 papers at the last edition, 7 more than at the previous edition,
  • Sapienza University of Rome (22 papers) published 5 papers at the last edition, 1 less than at the previous edition,
  • Tanta University (22 papers) published 6 papers at the last edition, 1 less than at the previous edition,
  • Shahid Beheshti University of Medical Sciences and Health Services (20 papers) published 7 papers at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 11.11% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 29.31% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.05% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 17.24% of all publications and 44.40% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Focus on Receptors for Coronaviruses with Special Reference to Angiotensin- Converting Enzyme 2 as a Potential Drug Target - A Perspective.

    Thea Magrone;Manrico Magrone;Emilio Jirillo

    (2020)
    201 Citations
  • MicroRNAs as Biomarker for Breast Cancer

    Taru Aggarwal;Ridhima Wadhwa;Riya Gupta;Keshav Raj Paudel

    (2020)
    60 Citations
  • The Potential Role of Pro-Inflammatory and Anti-Inflammatory Cytokines in Epilepsy Pathogenesis.

    Ali N Kamali;Zeineb Zian;José M Bautista;Haleh Hamedifar

    (2021)
    32 Citations
  • Molecular and Immunological Mechanisms Underlying the Various Pharmacological Properties of the Potent Bioflavonoid, Rutin.

    David Ong Cherk Yong;Sanggetha Raja Saker;Dinesh Kumar Chellappan;Thiagarajan Madheswaran

    (2020)
    27 Citations
  • A Review on the Effects of New Anti-Diabetic Drugs on Platelet Function.

    Habib Yaribeygi;Stephen L. Atkin;Tannaz Jamialahmadi;Amirhossein Sahebkar

    (2020)
    27 Citations
  • Boswellic Acids: A Critical Appraisal of Their Therapeutic and Nutritional Benefits in Chronic Inflammatory Diseases

    (2023)
    25 Citations
  • How Much Vitamin D is Too Much? A Case Report and Review of the Literature.

    Sara De Vincentis;Antonino Russo;Marta Milazzo;Amedeo Lonardo

    (2021)
    21 Citations
  • Italian Guidelines for the Management of Non-Functioning Benign and Locally Symptomatic Thyroid Nodules

    (2023)
    21 Citations
  • Diagnostic Approach to the Patients with Suspected Primary Immunodeficiency

    Marzieh Tavakol;Mahnaz Jamee;Gholamreza Azizi;Homa Sadri

    (2020)
    19 Citations
  • Clinical, Immunologic and Molecular Spectrum of Patients with Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome: A Systematic Review.

    Fatemeh Kiaee;Majid Zaki-Dizaji;Nasim Hafezi;Amir Almasi-Hashiani

    (2021)
    15 Citations

Related Online Degrees & Career Pathways

For those interested in Medicine in the USA, exploring related online degrees can provide valuable pathways and enhance your career prospects. An online biology degree programs offer a strong foundation in life sciences, crucial for medical school and healthcare research roles.

Nursing is another pivotal healthcare field, and an online ASN program can be a quicker route to entering the nursing profession with flexibility for working students. This degree supports hands-on patient care skills essential in medical settings.

Nutrition plays a key role in preventive medicine and wellness. Pursuing an online dietitian degree equips students with expertise in dietary science, opening career opportunities in hospitals, clinics, and community health.

For those aiming to lead in healthcare administration, enrolling in CAHME accreditation MHA programs ensures high standards of education and prepares graduates for management roles in medical institutions. These programs combine healthcare knowledge with leadership training vital for organizational success.

Best Scientists Contributing to This Journal

Recently Published Articles